logo
Plus   Neg
Share
Email

Stock Alert: Boeing Dives 7%

Shares of Boeing Co. (BA) are losing more than 7 percent on Wednesday morning at $138.24, despite the absence of any stock-specific news. The shares have traded in a range of $89.00 to $398.66 in the past 52 weeks.

Boeing is a component of the Dow Jones Industrial Average. U.S. stocks are sharply lower on Wednesday amid rising concerns about the coronavirus pandemic after White House officials warned of nearly a quarter million deaths from the pandemic.

During a White House press conference on Tuesday, President Donald Trump warned the U.S. is facing a "very, very painful two weeks."

Monday, Boeing had said it received a $1.5 billion production contract from the U.S. Navy for the next trance of 18 P-8A Poseidon aircraft. The U.S. Navy's contract comes at a time when the aircraft maker continues to struggle amid the 737 Max crisis and COVID-19 pandemic impacts. Boeing recently sought $60 billion in U.S. government loan guarantees and other assistance.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
Follow RTT